Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025LipidologyOpen Access

Liposomes as “Trojan Horses” in Cancer Treatment: Design, Development, and Clinical Applications

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJuan SabínASAndrea Santisteban-VeigaÓAÓscar Abelenda

Discussion

Loading...

Member takes

Overview

Observational analysis of drug delivery improvements in oncology, suggesting liposomes may enhance targeted treatment.

Key Points

  • Liposomal formulations improve drug delivery in cancer treatment, significantly enhancing targeted therapy efficacy.
  • Key parameters like particle size and zeta potential are optimized to enhance pharmacokinetics and biodistribution.
  • Design innovations include biodegradable systems for drug delivery within the tumor microenvironment, enabling better targeted therapies.
  • Advancements in physicochemical features have led to regulatory approvals for various liposomal formulations, support further clinical applications.

Cite This Study

Sabín et al. (2025) studied this question.

synapsesocial.com/papers/69401f0f2d562116f28fa376https://doi.org/10.3390/lipidology2040025
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Review on Liposomal Drug Delivery in Cancer Therapy2025
  2. 2Liposomal nanotherapeutics for cancer treatment: Targeted delivery and immunotherapy2026 · 2 citations
  3. 3Advanced Liposomal Systems for Cancer Therapy with Focus on Lipid–Polymer Hybrids and Cell Membrane-Coated Liposomes2026 · 2 citations
  4. 4Liposome-Based Drug Delivery Systems in Cancer Research: An Analysis of Global Landscape Efforts and Achievements2024 · 70 citations
  5. 5Translational Insights into Liposomal Drug Delivery: Recent Advances, Therapeutic Applications, and Clinical Trials2026 · 11 citations